
What happened
Aily Labs, an AI Decision Intelligence platform company, partnered with Google Cloud to make its platform available on the Google Cloud Marketplace. The move lets pharmaceutical and biotech firms buy Aily's AI agents directly through existing Google Cloud contracts, and those purchases count toward their committed cloud spend without triggering separate vendor reviews or new security evaluations.
Why it matters
Pharma and biotech companies typically juggle R&D, clinical trials, regulatory compliance, and supply chains across dozens of disconnected systems—delays in trial site selection, drug candidate prioritization, and inventory decisions often result. By offering Aily's platform through Google Cloud, enterprises can tap AI agents for drug development and regulatory work without extra procurement friction or security audits.
What to watch
Aily's "Super Agent" orchestrates thousands of specialized AI sub-agents across R&D, clinical development, regulatory filings, capital allocation, supply chain, and commercial operations—all accessible via the Agent Gallery within Gemini Enterprise, Google Cloud's enterprise AI application.
Summaries like this, in your inbox every morning.
Pharmaceutical and biotech enterprises operate across fragmented systems—R&D databases, clinical trial management, regulatory portals, and supply chain software often sit in isolated silos. This fragmentation creates operational delays when insights needed for drug candidate prioritization or trial site selection remain trapped in retrospective reports. Meanwhile, traditional enterprise AI deployments face delays from lengthy security audits, vendor onboarding, and contract negotiations, further slowing the journey from data to decision. Aily Labs' partnership with Google Cloud directly addresses both friction points. By placing the platform on Google Cloud Marketplace, the partnership allows companies already committed to Google Cloud to buy and deploy Aily's agents without new vendor vetting or security reviews—expenditures simply count toward existing cloud commitments. The integration into Gemini Enterprise's Agent Gallery further simplifies deployment, connecting Aily's specialized sub-agents to Google's foundation models and BigQuery data pipelines so that pharmaceutical teams can reason across their fragmented data in a single orchestrated interface.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
Supermicro Computer appointed Mark Long as chief financial officer, bringing an experienced technology finance…

Holtek Semiconductor unveiled its 2026 product roadmap on October 15, focusing on four core areas: smart prote…

TSMC reported about NT$763.1b in Q3 net profit and confirmed that demand for advanced processors is running ah…

Nvidia-backed CoreWeave steadied Thursday after a sharp slump, as investors worried about the debt financing b…

Circlia started a proof-of-concept for TASTE SIGNAL: visitors to Holland Village Cafe FUKUOKA taste cookies an…

Weathernews said on October 15 it implemented its own AI weather-forecasting model, AI-Nowcast, in its Weather…
